These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32774131)

  • 1. Assessing the Desmoid-Type Fibromatosis Patients' Voice: Comparison of Health-Related Quality of Life Experiences from Patients of Two Countries.
    Timbergen MJM; van der Graaf WTA; Grünhagen DJ; Younger E; Sleijfer S; Dunlop A; Dean L; Verhoef C; van de Poll-Franse LV; Husson O
    Sarcoma; 2020; 2020():2141939. PubMed ID: 32774131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Evaluation of Health-Related Quality of Life Issues Experienced by Patients with Desmoid-Type Fibromatosis (The QUALIFIED Study)-A Protocol for an International Cohort Study.
    Schut AW; Timbergen MJM; Lidington E; Grünhagen DJ; van der Graaf WTA; Sleijfer S; van Houdt WJ; Bonenkamp JJ; Younger E; Dunlop A; Jones RL; Verhoef C; Gennatas S; Husson O
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling Desmoid-Type Fibromatosis-Specific Health-Related Quality of Life: Who Is at Risk for Poor Outcomes.
    Schut AW; Lidington E; Timbergen MJM; Younger E; van der Graaf WTA; van Houdt WJ; Bonenkamp JJ; Jones RL; Grünhagen DJ; Sleijfer S; Verhoef C; Gennatas S; Husson O
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical symptom burden in patients with desmoid-type fibromatosis and its impact on health-related quality of life and healthcare use.
    Schut AW; de Bruin LE; de Rooij BH; Lidington E; Timbergen MJM; van der Graaf WTA; van Houdt WJ; Bonenkamp JJ; Jones RL; Grünhagen DJ; Sleijfer S; Gennatas S; Verhoef C; Husson O
    Cancer Med; 2023 Jun; 12(12):13661-13674. PubMed ID: 37119048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Disease-Specific Health-Related Quality of Life Questionnaire (DTF-QoL) for Patients with Desmoid-Type Fibromatosis.
    Schut AW; Lidington E; Timbergen MJM; Younger E; van der Graaf WTA; van Houdt WJ; Bonenkamp JJ; Jones RL; Grünhagen DJ; Sleijfer S; Verhoef C; Gennatas S; Husson O
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and assessment of health-related quality of life issues in patients with sporadic desmoid-type fibromatosis: a literature review and focus group study.
    Timbergen MJM; van de Poll-Franse LV; Grünhagen DJ; van der Graaf WT; Sleijfer S; Verhoef C; Husson O
    Qual Life Res; 2018 Dec; 27(12):3097-3111. PubMed ID: 30014458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life (HRQoL), anxiety, and depression in patients with desmoid type fibromatosis.
    Garg V; Rastogi S; Kalra K; Bhoriwal S; Barwad A; Dhamija E; Upadhyay A; Gamangatti S
    Support Care Cancer; 2022 Dec; 30(12):10089-10098. PubMed ID: 36350382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related Quality of Life of Patients With Non-Intra-abdominal Desmoid-Type Fibromatosis During Active Surveillance: Results of a Prospective Observational Study.
    Schut AW; Timbergen MJM; Nasserinejad K; van Dalen T; van Houdt WJ; Bonenkamp JJ; Sleijfer S; Grünhagen DJ; Verhoef C; Husson O;
    Ann Surg; 2023 Jun; 277(6):877-883. PubMed ID: 36727954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.
    Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC
    Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary thyroid cancer with extrathyroidal extension of desmoid-type fibromatosis. A case report of an aggressive presentation of an uncommon pathologic entity.
    Roth EM; Barrows CE; Nishino M; Sacks B; Hasselgren PO; James BC
    Int J Surg Case Rep; 2019; 63():5-9. PubMed ID: 31499326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular choristoma-associated desmoid-type fibromatosis: Establishing a nerve territory concept.
    Maldonado AA; Spinner RJ; Broski SM; Stone JJ; Howe BM; Carter JM
    Acta Neurochir (Wien); 2020 May; 162(5):1137-1146. PubMed ID: 31897730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials in desmoid-type fibromatosis in children and adults: A systematic review.
    van Maren SA; van Noesel MM; Husson O; van der Graaf WTA
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29831. PubMed ID: 35714333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated Signaling Pathways and Targeted Therapies in Desmoid-Type Fibromatosis: A Literature Review.
    Timbergen MJM; Smits R; Grünhagen DJ; Verhoef C; Sleijfer S; Wiemer EAC
    Front Oncol; 2019; 9():397. PubMed ID: 31165043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular choristoma and circumferential nerve territory desmoid-type fibromatosis: imaging findings supporting a nerve-driven mechanism.
    Maldonado AA; Broski SM; Carter JM; Marek T; Howe BM; Spinner RJ
    J Neurosurg; 2024 Jan; 140(1):1-9. PubMed ID: 37382327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Event-free survival in Desmoid-Type fibromatosis (DTF): A pre-post comparison of upfront surgery versus wait-and-see approach.
    Ruspi L; Cananzi FCM; Sicoli F; Samà L; Renne SL; Marrari A; Gennaro N; Colombo P; Cozzaglio L; Politi LS; Bertuzzi A; Quagliuolo V
    Eur J Surg Oncol; 2021 May; 47(5):1196-1200. PubMed ID: 32847695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET imaging characteristics of neuromuscular choristoma and associated desmoid-type fibromatosis.
    Marek T; Spinner RJ; Carter JM; Murthy NK; Amrami KK; Broski SM
    Acta Neurochir (Wien); 2023 May; 165(5):1171-1177. PubMed ID: 36917362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor.
    Skubitz KM
    Mayo Clin Proc; 2017 Jun; 92(6):947-964. PubMed ID: 28578783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis and mutation stratification of desmoid-type fibromatosis on MRI using radiomics.
    Timbergen MJM; Starmans MPA; Padmos GA; Grünhagen DJ; van Leenders GJLH; Hanff DF; Verhoef C; Niessen WJ; Sleijfer S; Klein S; Visser JJ
    Eur J Radiol; 2020 Oct; 131():109266. PubMed ID: 32971431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent desmoid-type fibromatosis associated with underlying neuromuscular choristoma.
    Stone JJ; Prasad NK; Laumonerie P; Howe BM; Amrami KK; Carter JM; Jentoft ME; Spinner RJ
    J Neurosurg; 2019 Jul; 131(1):175-183. PubMed ID: 30168738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.